Immunohistochemistry of p63 in primary and secondary vulvar Paget's disease

Pathology International

Volumn 58, Issue 10, 2008, Pages 648-651

  Yanai, Hiroyuki ^a   Takahashi, Narihisa ^b   Omori, Masako ^a   Oda, Wakako ^c   Yamadori, Ichiro ^c   Takada, Shin Ichi ^d   Matsuura, Hiroo ^d   Yoshino, Tadashi ^a,b  

^a OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c National Hospital Organization   (Japan)

^d HIROSHIMA CITY HOSPITAL   (Japan)

Author keywords

Immunohistochemistry; p63; Urothelial carcinoma; Vulvar Paget's disease

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7; PROTEIN P63; UROPLAKIN;

AGED; ARTICLE; BLADDER BIOPSY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAGET SKIN DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UROGENITAL TRACT TUMOR; UTERINE CERVIX BIOPSY;

AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; KERATIN-7; MIDDLE AGED; PAGET'S DISEASE, EXTRAMAMMARY; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER NEOPLASMS; VULVA; VULVAR NEOPLASMS;

EID: 51749123998     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2008.02284.x     Document Type: Article

References (12)

1. Wilkinson EJ, Brown HM. Vulvar Paget disease of urothelial origin: A report of three cases and a proposed classification of vulvar Paget disease. Hum Pathol 2002 33 : 549 54.
2. Goldblum JR, Hart WR. Vulvar Paget disease: A clinicopathologic and immunohistochemical study of 19 cases. Am J Surg Pathol 1997 21 : 1178 87.
3. Ohnishi T, Watanabe S. The use of cytokeratins 7 and 20 in the diagnosis of primary and secondary extramammary Paget's disease. Br J Dermatol 2000 142 : 243 7.
4. Brown HM, Wilkinson EJ. Uroplakin-III to distinguish primary vulvar Paget disease from Paget disease secondary to urothelial carcinoma. Hum Pathol 2002 33 : 545 8.
5. Moll R, Löwe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histologic marker detected by monoclonal antibodies. Am J Pathol 1992 140 : 427 47.
6. Wang NP, Zee S, Zarbo RJ, Bacci CE, Gown AM. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 1995 3 : 99 107.
7. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases. Mod Pathol 2000 13 : 962 72.
8. Moll R, Wu X-R, Lin J-H, Sun T-T. Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas. Am J Pathol 1995 147 : 1383 97.
9. Kaufmann O, Volmerig J, Dietel M. Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas. Am J Clin Pathol 2000 113 : 683 7.
10. Olson DJ, Fujimura M, Swanson P, Okagaki T. Immunohistochemical features of Paget's disease of the vulva with and without adenocarcinoma. Int J Gynecol Pathol 1991 10 : 285 95.
11. Compérat E, Camparo P, Haus R et al. Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 cases. Virchows Arch 2006 448 : 319 24.
12. Kaufmann O, Fietze E, Mengs J, Dietel M. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 2001 116 : 823 30.